← Open Payments lookup

NPI 1508856170: Open Payments

NPI 1508856170. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$414 in 5 payments from 3 companies in 2025. Trend: 2023 $3,936 · 2024 $1,746 · 2025 $414

Food & beverage: $414
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$246
Alpha Cognition USA, Inc.1$112
Alkermes, Inc.2$55

Products named: CAPLYTA, Zunveyl, ARISTADA, LYBALVI.